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ABSTRACT
Using a sample from the seven largest metropolitan areas in the United States,
(Denver, Chicago, Los Angeles, Atlanta, New Orleans, New York, and Houston),
consumer attitudes concerning agricultural biotechnology is examined. Conjoint analysis
is used to examine consumer preferences for the labeling of biotech foods. The study
examines the relationship between the consumer’s knowledge and attitudes regarding
biotech foods and their preferences for food labels. Consumers’ attitudes regarding a
healthy diet, and their risk perceptions regarding biotech foods were found to have a
significant effect on the general use of food labels and preferences for labeling of biotech
foods. The most significant finding of the study is that consumers prefer mandatory
labeling of biotech foods, rather than FDA’s current voluntary labeling policy.
The conjoint results show that the most important attribute regarding a biotech
label was the presence of a logo, contributing 48.7 % to the preference rating. A text
disclosure describing the benefits of the biotech ingredient was determined to be the
second most relevant attribute, accounting for 40.87% of the respondent’s preference
rating. The third most important attribute (contributing 10.43%) was the location of the
logo on the principal display panel (PDP) of the product package.
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CHAPTER 1
INTRODUCTION
The growth and development of agricultural biotechnology have resulted in many
new crops, along with changes in production practices and marketing activities of crops
and livestock products. A number of factors have combined to stimulate interest and
investment in agricultural biotechnology by farmers, processors and consumers. The
changing needs and preferences of consumers have created opportunities and markets for
new products that farmers and food processors are willing to produce and market. An
increasingly discriminating consumer who has an expanded interest in food safety,
labeling, nutrition and value-added enhanced qualities, also creates opportunities for
agricultural biotechnology expansion. Profit maximization, a dominant market share, and
control of the vertical integration system caused food processors to invest heavily in
research and development of agricultural biotechnology. Many agribusinesses, including
large food processors, have been able to develop and market field crops with qualities
and attributes that end-users desire and are willing to pay for. The major agribusinesses
involved in biotechnology are, Archer Daniels Midland, Advanta Seeds, American
Cyanamid, Cargil, Cebeco, Dekalb, Monsanto, Pfizer Incorporated and Zeneca. Farmers
were responsive to, and quickly embraced genetically engineered products because they
anticipated the benefits of reduced production costs, enhanced yields and increase profits.
Biotechnology is defined as the use of biological systems to produce a product,
the use of a biological system as a product, or the use of the techniques of biotechnology
to provide a product, process or service (Wiegele, 1991 p 21). Genetic engineering,
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which is a subset of biotechnology, is defined as the manipulation and alteration of the
genetic material (constitution) of an organism in such a way as to allow it to produce
endogenous proteins with properties different from those of the normal organism, or to
produce entirely different (foreign) proteins altogether (Nill, 1998). The terms
biotechnology, genetically engineered (GE) and genetically modified (GM) are often
used interchangeably throughout the scientific community, an approach that will be
adopted in this study.
Biotechnology reduces pesticide use, which helps protect the environment from
potential harmful effects of pesticides use. It allows production of crops with increased
resistance to pests, animals with increased resistance to diseases, and increase crop
yields. Biotechnology also has the potential to boost the nutritional value of foods.
Consumers, the end-users of all agricultural crops, benefit from biotechnology as they
obtain food products that are innovative, nutritious, and have enhanced traits or qualities.
The production and distribution of GE foods may also lead to changes in trade
patterns, because agricultural biotechnology increases the scope for substitution of one
commodity for another (Junne, 1997). Problems arise when one country is able to
introduce the new technology at a faster pace than others. The early adopters will be able
to increase their market share and will displace other countries as exporters. (Junne
1997). Less developed countries in Latin America, Africa, and the Caribbean will suffer
more as they lack the necessary infrastructure to be competitive in the production and
distribution of GE foods. Other concerns among trading countries are the health risks
associated with GM foods. The European Union has already banned some GE foods from
the U.S. for health reasons, putting a strain on US-EU trade relations. For instance, there
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is heightened interest in food safety and a greater distrust from European consumers
toward their government because of the recent technology crisis, associated with Bovine
Spongiform Encephalopathy (BSE). The influence of GE foods on international trade is
also affected by each country's economic and political climate. Political persuasions can
retard or boost acceptance, substitution and distribution of GE foods
Biotechnology has produced numerous crops and products that satisfy both
producers need for lower cost and increased profits, and consumers need for more
product diversity and consumer specific traits. For example, bioengineered cotton and
soybean seeds are two of the major crops that farmers welcomed because of their great
potential. Bacillus thuringiensis (Bt) technology has been developed for cotton to resist
damage from bollworm1, tobacco, budworm, and pink bollworm. With Bt corn, the plant
produces the insecticide throughout its life cycle, which eliminates the need for post
emergent pesticides spraying. (McBridge et al., 1999). These changes in production
practices avoid the possible contamination of water supplies and harm to the environment
that occurs during water run-offs.
One of the first major agricultural animal products from biotechnology is Bovine
Somatotropin (BST). BST, also known as bovine growth hormone (BGH), is a protein
made in the pituitary gland of cows (Schacter, 1999). Recombinant bovine somatotropin
(rbST) is BST produced by genetically altered bacteria in the laboratory. Laboratory
produced rbST, when injected in cows, increases their milk production (Aldrich et al.,
1998). The milk from cows given rBGH has the same product characteristic as the milk
from untreated cows (Grobe et al., 1997). In the U.S., BST was thoroughly tested and
studied before it was approved for commercial distribution. The Food and Drug
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Administration (FDA), an agency of the U.S. Department of Health and Human Services
(HHS) approved BST for U.S. sale and use on November 5, 1993 (Monsanto 1994).
Stefanides and Tauer (1999) found that adoption rates of bST by farmers were
consistent with previous ex ante bST adoption studies. The predicted aggregate adoption
rates ranges from 8% to 41 % for early adopters, and from 33% to 92% for eventual
adopters. In terms of production, adoption of bST, when viewed at the national level,
simply reinforces the trend toward increased milk production per cow and declining dairy
farms numbers. When viewed at the farm level, bST use could prove profitable for almost
all commercial dairy farms (Fallert et al., 1994)
On the other hand, consumer acceptance of products produced from
biotechnology has been slow despite their excellent prospects. New technologies in food
supply and increased knowledge of the link between diet and health have resulted in
consumers having a greater interest in food qualities and safety issues (Caswell et al
1997). This is due largely to fears that GE foods are unsafe and could cause long-term
health problems giving rise to public debate over the potential risk associated with GE
foods. For biotechnology to be successful it has to be accepted by consumers who first
must understand the science behind the process. It becomes imperative for farmers,
processors, the private industry, government and the media to join resources and educate
the public about the benefits and safety of genetically engineered products.
Labeling of genetically engineered foods has caused concerns among food
processors. According to Economic Research Service (ERS), labeling of food in the
United States is geared toward solving problems of asymmetric information, where
content and nutrition disclosures are not typically used as a standard tool to alert
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consumers about possible unsafe foods. The Food and Drug Administration (FDA), the
leading authority on food labeling, requires genetically engineered foods to be labeled
only if they differ significantly from their conventional counterparts. The question
remains though, what are the effects of separating and labeling of GM foods and non-GM
foods? Is there a direct relationship between labeling and success of GM foods? Food
labeling regulation can hinder trade and distribution of GM foods and results in increased
cost (marketing cost) to consumers. The challenge facing the agriculture industry is the
stimulation and education of consumers. While the market will always adjust to changes
in consumer needs, the marketplace must also help to shape consumers preferences and
choices by providing information that is credible and readily available.
The introduction of any new product for public consumption will undergo
scrutiny and potential consumer resistance due to lack of awareness and
misunderstanding. Animal food products in particular raise concerns because consumer
surveys seem to document less acceptance of genetic modification of animals than of
plants (Aldrich and Blisard, 1998). However, consumer views toward biotechnology are
generally positive. Sixty-seven percent of consumers in a national sample agreed that
biotechnology would personally benefit them in the next five years (Hoban and Kendall,
1992). Milk sales remained steady after rbST became available to farmers, even though a
multitude of public opinions surveys documented widespread concern about food safety.
The rbST experience suggests that, while scientific evidence of food safety will not
prevent controversy over biotech foods, controversy will not necessary inhibit consumer
demand for the food.
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Problem Statement
The introduction of biotech foods and the debate over food safety and labeling has
led to U.S. policy makers to make some difficult choices, often trying to appease both
farmers and consumers. The problem is compounded because policymakers, who often
base policy decisions on the results of scientific studies, frequently do not understand the
seemingly irrational concerns held by consumers (Baker and Crosbie, 1993). New
technologies in food supply and increased knowledge of the link between diet and health
have resulted in consumers having a greater interest in food qualities and safety issues.
(Caswell et al., 1997). This is due largely to fears that GE foods are unsafe and could
cause health problems giving rise to public debates over potential risk associated with GE
foods. Labeling biotech and non-biotech foods has caused some concern as advocates
argue for the right to know by consumers. However, the Food and Drug Administration
(FDA), the leading authority on food labeling requires genetically engineered foods to be
labeled only if they differ significantly from their conventional counterparts.

Public

concerns over GM are strong despite a library of scientific evidence of its safety (Aldrich
and Blisard 1998). Notwithstanding, resistance to GMOs still exists due largely to
consumers in general having little comprehension of all facets of GE products. When this
happens consumers will naturally perceive more risk to be associated with the product,
when in actuality, it is not. Thus, the problem addressed in this study is to conduct a
detailed analysis of individual consumer preference for GM foods and the labeling of
these products.
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Statement of Research Objectives and Questions
Potential consumer resistance to animal food products produced from
biotechnology continues to raise uncertainty among analysts of the food system. The
production of GMOs such as bt corn and rbST has come under continued scrutiny. There
are groups demanding that products produced from biotechnology be labeled as such.
However, the guiding principle of Federal regulation of food products from
biotechnology is that the product, not the process, be regulated (Caswell et al., 1997). In
the case of rbST, the milk was determined to be safe and was not different from other
milk and therefore no special handling or labeling is required. Given this, it becomes
necessary to determine whether knowledge of the production method will influence
consumer evaluation of the biotech products. The overall goal of this study therefore is to
examine the adoption of GMOs by US consumers and their preference for products
labeled biotech compared to products made from the tradition production processes. The
study encompassed three specific objectives:
Specific Objective1:
To measure consumer attitudes and perceptions towards foods produced using
biotechnology. It is hypothesized that consumer acceptance of genetically engineered
foods is influenced by concerns for more healthy diets and the potentially harmful effects
of biotechnology on the environment. The nature of this relationship will be examined
through the use of a questionnaire.
Specific Objective 2:
Quantify labeling preferences regarding genetically engineered foods and to
examine consumer attitudes toward a mandatory versus a voluntary labeling policy for
biotech foods. The process of estimating consumers’ labeling preferences will be
7

accomplished using conjoint analysis. This model will be used to determine the value that
consumers place on particular combination of labeling attributes, such as nature of
information disclosure, use of a biotech logo, and the position of biotech information on
the label. Also, consumers’ choice between a mandatory or voluntary labeling policy
will be analyzed.
Specific Objective 3:
To determine the frequency of consumers’ use of food labels in general. Unless
products are labeled, consumer may be unaware of the nutrients or ingredients they
contain. Labels serve as a source of information and reduce uncertainty. A questionnaire
will be use to identify consumers’ propensity to use food labels.
Organization of Study
In the next chapter, previous research and relevant literature is reviewed and
summarized. Chapter three describes the methods used in the study, which includes the
experimental design, empirical methods, questionnaire design and attributes used in the
conjoint analysis.

Chapter IV focuses on the discussion of empirical results and

interpretation. This study concludes with chapter V which offers the summary,
conclusion, limitations, and suggestion for further research.
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CHAPTER 2
LITERATURE REVIEW
The production and marketing of genetically modified food products has caused
many concerns, particularly from an increasingly discriminating consumer. Consumers
are concerned, not only about the price of GMP’s, but also the long-term impacts of
GMP’s on the environment, the moral, ethical and religious implication of both
manufacturing and consuming the product, and most importantly, human health. The
acceptance and success of genetically engineered food products will be greatly influenced
by an expanded set of consumer interests. Today’s consumers are placing increasing
importance on food quality, food safety and environmental quality now more than ever.
The results of surveys of consumer attitudes toward food biotechnology conducted since
the introduction of the technology found that issues related to biotechnology and its
acceptance can be grouped into three major categories: (1) credibility issues related to
industry and its government regulators, (2) safety issues relevant to individual consumers
as well as the environment, and (3) the right to know by consumers, the matter of
labeling.
Several studies have analyzed the more general relationship between
socioeconomic factors, the perceived risk associated with genetically modified food
products, and in general food safety concerns (Baker et al 1993, Grobe et al 1997,
Caswell 1994, Holland and Wessells 1998). Results indicated that there are substantial
differences between consumer segments in terms of their willingness to pay for food
products certified as safe. Social and cultural factors such as gender, education, age,
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household size, ethnicity, environment and animal rights contributed to consumers having
different risk perceptions.
Baker et al., (1993) identified consumer segments based on a detailed analysis of
individual consumer preferences for food safety attributes in respect to apples. Consumer
segments were constructed by using cluster analysis to form groups, which were
homogenous with respect to preferences regarding food safety. Conjoint analysis was
then used to estimate individual preference function for food safety attributes. Market
simulation was conducted in San Jose, California, where shoppers were asked to
participate in a survey for a $10 incentive payment.
Price and quality attributes were considered for each product. The products and
their attributes provided a consumption service. An indirect utility function was derived
which indicated consumer’s purchase decision for a product. This function was based on
product attributes, price of the product, and attributes and prices of other products as well
as each consumer’s income level.
The utility function for each respondent was specified in terms of a combination
rule W and a set of function forms WK as W (w1 (z1),…, wk (zk). Where ZK is a set of
characteristics for a product. Hypothetical products were presented in a manner that
describes the products fully in terms of their attributes levels. Four factors, price, damage
certification program, and pesticides regulation (each with three levels) were used to
evaluate preferences for fresh apples. Results indicated that there were substantial
differences between consumer segments in terms of their willingness to pay for certified
products. However, individuals in three different segments were willing to pay a
substantial price premium to ensure that produce meets safety standards.
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Grobe et al., (1997) also studied consumer risk perception. The qualitative
multinomial logit model (LIMDEP econometric software) approach was used to measure
consumer risk perceptions and provide understandings of how individual differences
affected or contributed to their overall treatment of risk. The risk perceptions of foodrelated biotechnology, recombinant bovine growth hormone, (rbGH) was examined in the
analysis. A survey was conducted nationwide and lasted from March 1, through June 27,
1995 with 1,910 interviews. A sub-sample was created which grouped respondents into
two major groups, those who were aware of rbGH and those who had no prior knowledge
of rbGH. These two groups was further divided into seven categories depending on the
respondent’s perceived risk and their resulting behavior. Respondents were further
divided on variables such as personal health influences, which is affected by heredity,
personal concern and lactose tolerance. Gender, education, age, household size, ethnicity,
environment, animal rights and “poor” defined social and cultural influences. The “poor”
category was based on the USDA’s poverty guidelines, February 9, 1995.
The study found that groups of consumers with shared information on rbGH had
variable beliefs and displayed roles relating to their personal preferences. For example,
there were consumers who were unaware of rbGH’s use, but were provided the same
brief description of rbGH, still exhibited different risk perception responses that ranged
from believing that product was safe to perceiving personal susceptibility. The study also
found that those who engaged in protective actions were highly correlated with
environmentalist concerns. This suggests that food safety concerns were just as important
as rbGH and the environment. No one public policy would likely satisfy all consumers. It
is therefore important for policy makers to understand that consumers differ in their
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behavioral response to perceived risk and in so doing, only then will risk communication
strategies be successful.
Caswell et al., (1994) took a more holistic approach. Biotechnology was looked at
from an economic perspective. The study found that factors such as public policies,
producers’ expectation and consumers demand for new products have affected the supply
of agricultural biotechnology products. An expected increase on profitability by farmers
and processors create a demand for biotechnology applications. However, the market
(sellers and buyers) for biotech products sectors will depend on consumer demand for
biotech-derived agricultural products.
Another survey analyzed consumers’ perception about food safety and
biotechnology in developed countries such as the United States, Australia, United
Kingdom and Japan. Hoban (1999) studied consumer awareness and acceptance of
biotechnology and willingness to purchase GM foods. Telephone surveys were conducted
in both Japan and the United States from 1995 to 1998. Results indicated that an
increasing number of consumers were willing to purchase genetically modified food
products. The study also found that consumers in the United States were more aware and
had a greater understanding of biotechnology compared to their Japanese counterparts.
In terms of adoption and use by farmers, various studies have been conducted,
and all studies have shown similar results. “The empirical Impact of Bovine
Somatotropin on a group of New York Dairy Farms” by Zdenko and Tauer (1995)
showed increased milk production per cow, however the impact on profits was not
statistically different from zero. Data from 211 New York dairy farms were used to
estimate ex post rbST adoption function and to measure the impact of rbST on milk
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output and profitability. They found that rbST was not profitable on average. They
concluded that a learning phase is needed for farmers to understand how to make optimal
use of the new product. This study was done in 1994, the first year of rbST availability
which impacted the findings greatly.
Two other studies on farmers’ adoption were done in California and Wisconsin.
The Wisconsin study by Barham (1996) showed that adoption in this state is consistent
with a politicized constrained path, and farmers adoption rates were very low. Barham
argued that bST’s diffusion and adoption in Wisconsin has not followed the classic
sigmoid growth of rapid acceleration. Zepeda (1990) used an ex ante adoption model to
predict adoption of rbST by California dairy farmers. Five categories of respondents were
analyzed. They included user, non-user, waiter, don’t know, and haven’t heard. There
were significant differences between all five categories of respondents. Potential farmer
adoption of bST, based on the waiter and use categories, were 44%, a rate lower,
compared to results from other studies for other regions. This can be attributed to other
research that indicates that diffusion rates of highly concentrated industries are lower than
less concentrated industries.
While some of the studies in the United States found that Americans favor the
technology, such support is not always universal. In Australia, a national government
survey of 1,378 people showed that 89% of respondents said that genetically engineered
tomatoes should be labeled so that people could decide whether they wanted to eat these
tomatoes or not. Only 4% percent were against labeling. About 65% percent said that
labeling engineered tomatoes would be a good idea, while 65% percent said that
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unlabeled engineered tomato would be a bad idea (www. consumersinternational.org/
campaigns/surveys.html)
The effect of biotechnology on agricultural production and profitability will
depend on the demand characteristics of the products to which the technology is being
applied. As previously mentioned, acceptance and success of biotechnology will be
greatly influenced by an expanded set of consumer interests. Today’s consumers are
placing increasing importance on food quality, food safety, and environmental quality.
Additional information in the form of product labeling is one proposed way to provide
information consistent with public concerns. According to Caswell et al., (1999), the
uncertainty of consumer reactions is the largest impediment to assessing the future
potential of biotechnology in U.S. agriculture.
For GMOs to be successful there must be full market access and market
acceptance of the product. Isaac and Phillips (1996) said that consumer concerns and
acceptance are impeded by two factors. These include the perception of the primary
benefits of GMPs and the perception of control over GMPs. Presently, most consumers
see producers as the major beneficiaries of GMPs. Issac and Phillips (1996) concluded
that until the advantage seen in productivity is translated into significant decrease in
prices, or until the new applications target attributes desired by consumers, consumers
will continue to believe that they don’t receive any benefits from biotechnology
adaptations. Since consumer acceptance is a function of the consumer’s understanding of
perceived risk and benefits, more transparent information is needed to enhance these
consumer’s understanding of the risk and benefits.
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Market acceptance and product regulations are correlated, as consumers cannot be
offered products without government approval, and governments who are sensitive to
public interest, will not approve products unless consumers are confident genetically
engineered foods (GE) are safe. The type of government regulation employed to address
consumer concerns will affect market access and consequently the development and
commercialization of agricultural biotechnology. Approval by regulatory agencies for
biotech products, however, does not always equal acceptance by consumers. Producers
must therefore take a proactive role in disseminating information about the benefits and
risks of biotech products, and not rely on regulatory agencies (Isaac and Phillips, 1996).
One of the most challenging issues surrounding genetically engineered foods
involves labeling and the consumer right to know. The general issue of food labeling has
been debated in many forums. Food labels provide many benefits. They allow producers
and marketers to communicate to potential buyers information about their product
offerings. This information is then used by consumers for product evaluation and
selection. Food labeling has become a policy issue for Americans (policy makers and
consumers) because more emphasis is now being placed on nutrition. Subsequently, the
Nutrition Labeling and Education Act (NLEA) of 1990 replaced the voluntary system of
labeling established by the FDA in 1973. The act requires mandatory nutrition labeling
for packaged food and strict regulation of nutrition content and health claims. The
characteristics of GE food labels will have a significant effect on consumers’
understanding and acceptance of biotechnology. In general, informational labeling is
being used as a means of (a) shaping consumers’ knowledge, purchasing patterns and use
practices, and (b) manufacturers’ product offering and marketing practices (Caswell and
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Mojduszka, 1996). The right to know by consumers of ingredients used to produced food
products, the matter of labeling has received considerable attention and study
One study relating to the labeling of GE foods was conducted by the Wirthlin
Group Quorum Survey. Approximately 1000 telephone interviews were conducted in
March 1997, February 1999, and October 1999. When asked how informed they are
about biotechnology, less than 20 percent of consumers felt they were very well informed
about the technology. The study found that on average, 78% of Americans support the
current FDA labeling policy for biotech foods. The present policy of the FDA is that
labeling of biotech foods should be voluntary, since it has been determined these foods
have the same safety and nutritional contents as other foods. According to the study,
consumers were still likely to agree with the labeling position of the FDA’s even after
they were told of the mandatory labeling policy as argued by critics of the FDA. Critics
of the policy say that any food produced through biotechnology should be labeled, even if
the safety aspect of the food has not been altered.
According to Hallman et al., (1995), 84% of the 604 residents surveyed wanted
mandatory labeling on engineered fruits and vegetables. Sixty percent of the population
would consider buying fresh vegetables if they were labeled as having been produced by
genetic engineering. Also, 58% would not specifically look for biotech labels while
shopping. Forty-two percent of the people who said they would look for produce labeled
as not genetically engineered, also said they would buy produce that was genetically
engineered if the label gave this information. Other studies by Hoban and Kendall (1992),
Maki (1995), Douthitt (1990), and Novartis (1997) found that most Americans want
foods that are genetically modified to be clearly identified with labels.
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Economics of Labeling
Since the introduction of agricultural biotechnology, issues associated with food
labeling are having a significant impact on the food industry. The widespread use of
labeling and the emphasis the legislature places on labeling requirement suggests that it is
an effective way of altering the behavior of both producers and consumers. Over the
years, labeling was thought of as a direct shopping aid for consumers. However, Caswell
and Padberg (1992) argued that the roles of labeling should include; influencing product
design, advertising, promoting consumer confidence in food quality, and contributing to
consumer education regarding diet and health. Evaluating the effectiveness of labeling
programs requires understanding how information affects market behavior and the
benefits and costs of these programs. That is, what characteristics of the interaction
between the label, the consumer, and the product affect the impact of information (Teisl
1999). The effectiveness and utilization of different labels will vary across consumer
groups, and depends on various socioeconomic and demographic criteria such as
education, ethnic background, and income levels. These characteristics may be associated
with the benefits and costs of consumer information usage (Wang et al., 1995)
When asked if labeling is an effective policy tool for providing information about
food products, consumers usually answer yes, indicating that labels improve their
information set and guide their buying decisions. They also may make the market work
more efficiently as competition among firms, in an improved information environment,
awards success to products with the best attributes, as argued by Caswell and Padberg
(1992). From these viewpoints, it can be said that food labels are successful. However
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Variyam, Blaylock, and Smallwood, (1995 and 1997) and Mooran (1996) have found
labels to be unsuccessful in educating consumers and changing consumption behavior.
These studies found that consumers often make hasty food choices in grocery stores and
usually do not examine food labels.
Labeling will generate some benefits and also some cost. Policy makers must
weight the benefits and cost to determine whether labeling is an appropriate policy
option. The primary benefits of any governmental labeling program are changes in social
behavior and informed consumption of food products. Labeling could also result in
higher per-unit cost for producers and manufacturers. As a result, consumers will pay
higher prices for the same food products and small firms may be placed at a competitive
disadvantage.
Americans are becoming increasingly aware of the importance of nutrition, and
the linkage between diet and health. Coupled with the introduction of genetically
modified foods, informational labeling and food labels have become the focus of
increasing attention and research. Labels therefore become a primary information set
used by consumers in making product selections. Previous studies have indicated that
consumers desire labels to indicate the presence of genetically modified ingredients
(Huffman et al., 2000). Presently, no study has been done on the labeling characteristics
preferred by consumers for biotech foods, or the effects of consumer attitudes regarding
the safety of biotech foods and labeling preferences. These issues are important because
US consumers have different risk perceptions regarding the safety of biotech foods, and
posses varying demographic characteristics.
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This study attempts to determine label characteristics for genetically modified
foods, preferred by different groups of consumers. The study contributes to previous
literature because it further explores consumer understanding and usage of labels in
general, and how these factors affect their use and understanding of biotech labels. Since
the introduction of biotech foods, a lot of information (from scientists, industry leaders
and government) debate, media scrutiny, and views from the general public have become
known. These actions will have a major influence on the present and long-term viability
of the biotechnology industry. The influence will no doubt be lead from consumers. How
has views and perceptions changed since these major studies were done? To further
understand present and future preference of consumers regarding genetically modified
food products is one of the objectives of this study.
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CHAPTER 3
REVIEW OF CONJOINT ANALYSIS THEORY
Introduction
This chapter discusses the steps involved in the implementation of conjoint
analysis (CA), and the theoretical and practical reasons for using conjoint analysis as a
measurement technique for this study. The first part of this chapter begins with a
discussion of the history of conjoint analysis. Also included in the first section, is a
review of consumer utility as the foundation on which conjoint analysis is built. The
second part of this chapter covers the steps in the conjoint analysis process, including
attribute selection, experimental design, survey design, data collection, and model
specification.
Previous researches on new product development and identification of buyer
preferences have focused on techniques such as contingent valuation (CV) and conjoint
analysis. The accelerated growth of biotechnology and its applications may be considered
a new product to consumers. As a result, an understanding of how consumers evaluate
products based on various attributes is necessary for maximum buyer acceptance of
products produced from biotechnology.

Empirical estimation of the importance of

attributes for biotech labels will be accomplished using conjoint analysis.
Conjoint Analysis
Conjoint analysis is a multivariate technique used to estimate or determine how
respondents develop preferences for products or services (Hair et al., 1998). It is widely
used in marketing research and is based on the premise that consumers evaluate the value
of a product by combining the separate amounts of value provided by each attribute of
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the particular product or services. According to a survey by Cattin and Wittink (1982),
approximately sixty percent of all conjoint studies are related to consumer goods, twenty
percent to industrial goods, and the remaining 20 percent are performed for transportation
and financial services. These applications were used primarily for new product/concept
evaluation and pricing decisions. Conjoint analysis has also proven very successful in
market segmentation. (Green and Srinvasan 1978). Heterogeneous groups of consumers
are divided into homogeneous segments so different marketing strategies can be tailored
to each segment.
Conjoint analysis provides valuable information about bundles of attributes that
represent potential products or services for consumers. CA therefore provides researchers
with insight into the composition of consumer preferences by examining the attributes
that are most or least important to the consumers. These attributes form the basis for a
decision criteria that a respondent uses to choose products or services. In CA, products or
services are referred to as profiles, treatments, or a stimulus. Consumer preferences,
needs, and attitudes are reflected in their choices among product profiles. A profile is
defined as a hypothetical product consisting of different attribute - levels as shown by
diagram 2.1 below.

Profile

Attribute A

Level A1, A2 or A3

A3
B2
C1

Attribute B

Level B1, B2 or B3

Attribute C

Level C1, C2, or C3

Figure 3.1 Relationship Among Profile, Attributes and Levels.
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CA is the tool used in this study because it allows researchers to determine which
attributes of a product are liked or disliked. Thus, the tradeoffs consumers make among
attributes will be determined. Attributes are the key product characteristics that buyers
consider in their assessment of products. Because of their importance in decision-making,
each attribute must be distinct and represent a single concept and should include the
features most relevant to the potential buyer. Factors that must be considered in choosing
attributes include: (1) the number of attributes, where too many increases the number of
profiles a subject must evaluate (Hair et al., 1998), and (2) attribute multicollinearity
which implies there is a high correlation between two attributes. Examining the
correlation matrix is one way of detecting multicollinearity. Multicollinearity is present
when the correlation coefficient is greater than or equal to 0.80 (Kennedy, 1998).
Combining the two related variables to form one variable, or eliminating one attribute
altogether will solve this problem. CA allows for assessment of the relative importance
of each attribute by determining a person’s part worth utility for each attribute-level.
Having estimated part worth utility, total utility of individuals can then be estimated for
any combination of attributes. A relatively large range between part worth values
associated with an attribute-level suggests it is of relatively high importance. Various
combination of part worth values provides a utility index that is a function of attributelevel combination.
Preferences and Utility
Utility, which is subjective and unique to each individual, is the conceptual basis
for measuring consumer demand in economic theory. Economic theory states that utility
is interpreted as a numerical measurement of the satisfaction derived from the
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consumption of alternative bundles of commodities. In recent years, the theory of
consumer utility has gone beyond the traditional economic theory of consumer demand.
According to Lancaster’s model of consumer behavior, the theory of brand preferences
states that good are valued for the attributes they possess, and that differentiated products
are merely different bundles of attributes.
Marketers are interested in the characteristics of products or services that are
important to consumers. This is very important because they are better able to design
their products and position them to achieve a competitive advantage. Individuals in their
decision making process evaluate the benefits and costs of competing products before a
final choice is made. This process is a complex one.

Consumers use judgements,

impressions, and evaluation of all competing products attributes before they make their
final choice. In this process, consumers combine (integrate) information about different
determinant attributes to form overall impressions of product profiles, a process that
conjoint analysis is built upon, and is known as information integration theory (IIT),
(Louviere, 1988). ITT has three stages, which includes valuation, (psychophysical
judgement formation) integration, and response formation (Ozayan, 1997). The final
choice is the one that provides the individual with the highest level of total utility. The
utility index provides a framework for evaluating consumer preferences for the labeling
of biotech food products.
The Composition Rule
A composition rule is used in conjoint analysis to explain an individual’s
preference structure. It explains how respondents combine part worth values to form total
utility. There are two models often used to demonstrate the composition rule. One
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approach to the composition rule utilizes interaction effects which allow for certain
combinations of levels to be greater or less than their individual sums. The second, the
additive model uses only the main effect of the attribute. The additive model which is the
primary form used in CA allows respondents to add up the values for each attribute to
attain a total value for the bundle. The additive model, is the most common because it
accounts for most of the variation in respondents preferences (Green and Srinvasan,
1978). However, the interactive form may be a more complex representation of how
respondents value products and services. The additive rule is used to describe how
consumers combine part worths. In the additive model, each respondent’s total utility is
the sum of the part worth of each attribute. This means that the attribute impact on utility
is independent of the levels of other attributes.
The multiplicative model on the other hand indicates that response difference
corresponding to the levels of attributes can grow closer together or farther apart as the
levels of another attribute are present or not. In this case differences between responses
for the good-good and good-bad levels are not equal to the bad-good and bad-bad levels.
(Stringer, 1999). Use of an interactive model decreases the predictive power of the model
because an increased number of part worth estimates reduce the statistical efficiency.
This increase in the number of parameters increases the burden of rating or ranking on
the part of the respondents and will most likely decrease the reliability and validity of
responses. Moreover, several studies cite that interaction effects are negligible on model
results (Hildreth et al.,1998, Harrison et Al., 1997). For this reason, a main effect additive
model is used in this study.

24

Data Collection
The next step in CA involves the method of data collection. The issues of data
collection for this study were the questionnaire design, the selection of a technique for
survey administration, and the method of presentation for conjoint data collection. The
aim is to present to respondents various attribute combinations i.e., product profiles that
facilitate effective preference evaluation. Presentations can either be in a written or
pictorial format. There are three main presentation methods. They include the trade-off,
full-profile and pair-wise comparison methods. These methods will be discussed in the
next section of this study.
Methodology
This section outlines the steps used to evaluate consumer attitudes concerning
agricultural biotechnology and labeling formats for food products made using
biotechnology. Steps of CA include: 1) attribute selection, 2) experimental design, 3)
Questionnaire/survey construction, and 4) selection of an empirical model. Attribute
selection plays an important role in CA because it affects the accuracy of the results and
the relevance of the stimuli to real managerial decisions. Once the attribute and attribute
levels have been selected, they must be combined into hypothetical products for
respondents to rate or rank. This forms the basis for the experimental design, where
respondents are shown various forms of a product and then asked to evaluate the different
hypothetical products. In effect, the experimental design allows researchers to assess the
effect of one or more independent variables (the attribute-level) on the dependent variable
(product rating). To administer conjoint analysis, surveys are used as the data collection
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method. The empirical model was designed based on the theory of complex decision
making described in Louviere (1988, pages 12 -13).
Attribute and Level Generation
CA assumes that individuals evaluate product attributes in forming their
preference for alternative products or services. It is critical to have a carefully thought out
list of attributes. A list of too many attributes can greatly increase the burden on
respondents since many attributes require evaluation of numerous product profiles. A list
with too few attributes can reduce the predictive capabilities of the model because key
pieces of information are missing from the model. The critical factor in specifying
attributes and attribute levels is that a product cannot be accurately simulated if the
product is not adequately defined. Attributes included in a conjoint study should be those
most relevant to potential customers. An attribute is relevant to a product or conjoint
survey if overlooking its existence leads to different predictions about the choice or
ordering of the goods by the consumer. If the attribute does not positively or negatively
influence a consumer’s preference function, it is considered irrelevant. (Lancaster, 1971).
Attributes should represent a single concept, and be able to be used in the model so that
any perceptual differences among individual are minimized. For example, an attribute
such as quality should not be included and be specified by levels such as high, medium or
low, because quality is relative and individuals will perceive quality differently. It is
equally important when selecting attributes, to select their relevant levels, an important
factor to consider because a balanced number of levels protects against attribute bias
(Stringer, 1999).
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A number of methods exist to identify attributes of interest. These include
literature review, focus group discussions, and individual interviews. In the initial phase,
identification of the appropriate attributes and their relevant levels, a focus group session
was used. Since this study deals with consumers’ attitudes toward agricultural
biotechnology and the labeling of these types products, focus group interviews would
provide the attributes that are most important and those that most influenced the
respondent preference toward labeling preferences.
Focus Group Discussion
Researchers often use qualitative research methods to gain insight into consumers’
preferences (Teague et al 1995). One frequently used qualitative research method are
focus groups research. Focus groups are very important, not only because they aid in
developing questions for the questionnaire, but in providing the researcher with the forum
where individuals’ beliefs, opinions, and perceptions can be explored. Focus group
interviews consist of between six and twelve participants in which the researcher
moderates a group discussion on the topic of interest (Harrison et al., 1998). Although
small in numbers, focus groups uncover attitudes and opinions found in the general
population. Small groups are preferred to large group because interaction among group
members is increased, which facilitates discussion in greater depth. Advantages of focus
group research includes an increased interaction between all participants and the
researcher, visual aids and tangible products can be circulated, and areas of specific
interest can be covered in greater depth. Some disadvantages of focus groups include, the
need for experienced researches, the complexity to organizing, and the procedure is
expensive when compared to other methods.
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The focus group for this study consisted of a heterogeneous mix of people who
were primary shoppers for their household. The focus group discussion was conducted on
October 17, 2001 and was attended by six participants, five females and one male from
the Baton Rouge area who were recruited randomly from the phone book. The purpose of
the focus group was to, (1) obtain information regarding the consumers’ general
knowledge about biotechnology, (2) identify labeling characteristics that are most likely
to contribute to the consumer’s preferences and understanding of GMOs, and (3) better
understand why consumers may have concerns or fears of GMOs. The focus group
session follows the following outline: first, the moderator introduced the general topic of
biotechnology and its applications in the food system. Participants were asked to briefly
describe what they knew about biotechnology. The moderator then guided them through
a discussion about biotechnology and labeling issues in general. Handouts with
information on biotechnology were distributed to each participant. Information included
(a) a scientific definition of biotechnology, (b) examples of food that contained
genetically modified ingredients, (c) agencies that are responsible for food labeling and
food label requirements in the U.S., and (d) information provided by food labels.
The second part of the focus group focused on labeling of products using
biotechnology. Participants were presented with twelve different examples of biotech
food labeling. The labels differed in terms of (1) the use of a biotech logo, (2) text
disclosure of biotech ingredients, (3) agencies which inspect and approve food products
for human consumption. Participants were asked to rank their choices from one to twelve
in terms of the label presentations they deem most useful in providing information about
biotechnology. Participants then were asked to discuss their preferences with group
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members. The following is a brief description of the labels formats presented to the
participants.

·

Label A - simple disclosure, “ contains genetically modified ingredients”

·

Label B - “GE” logo, plus inspected and approved by the FDA

·

Label C - “GE” logo plus inspected and approved by the FSIS

·

Label D - “GE” logo, plus contains genetically modified ingredients

·

Label E - the presence of a logo “GE”

·

Label F -

text disclosure, “genetically modified to increase vitamin A

content”
·

Label G – text disclosure, contains genetically modified ingredients, long
term effect not known

·

Label H - Less than 5% of ingredients are genetically modified.

·

Label I - “GE” logo, plus “less than 5% of ingredients are genetically
modified”

·

Label J - “GMO FREE”

·

Label K - text disclosure “Genetically modified to reduce pesticides use”

When asked how knowledgeable they were about biotechnology, most
participants demonstrated some awareness of what biotechnology involves or is
associated with. One participant said “ It’s the way they are changing food in a scientific
way.” Another participant made reference to “breeding chickens to have a desired trait”
as what comes to mind when biotechnology is used. When asked if terms such as
genetically engineered, genetically modified, genetically modified organism (GMO) or
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biotechnology were the same in meaning, participants thought they meant the same,
although one participant thought biotechnology sounded safer. When asked if they could
presently identify any biotech foods in their supermarkets, most respondents said they
could not. However, one participant said that tomatoes she had seen in the market could
possibly have been genetically engineered. In general, participants were surprised to learn
about the number of consumer food products that contain genetically modified
ingredients. When asked where on the package should a biotech disclosure label be
placed, 83% of the participants said on the Principal Display Panel (PDP) and the
disclosure should be a logo only.
After collecting the ranking responses, the moderator facilitated participants’
discussion of the preferred attributes, and those that were not chosen. Label E received
the largest total number of first or second place rankings. Participants thought this format
was simple and short and is more likely to be seen relative to longer messages. Based on
the discussion, participants believed that before Label E can be effectively used, there
must be a nationwide education program to provide more information to consumers about
biotechnology and labeling. Label D, which was a combination of a logo and a text
disclosure, was the participants’ second choice. Label D was chosen because participants
said it presented a lot of information. Label G, (caution statement) received very low
rankings because participants believed it focused on health and risk, and tells of some
inherent danger or risk in using the product. Labels B and C also received low rankings
because participant say most times they don’t trust regulatory agencies.
In term of the type of disclosure, participant rankings varied widely. Sixty seven
percent of the participants believed that food products should be labeled GMO if contents

30

contain any trace of genetically modified ingredients. One participant believed that food
products should be labeled GMO only if contents contain more than 50% of genetically
modified ingredients. Another believed that labeling should not be required regardless of
the amount of genetically modified ingredients. When asked specifically if they would
buy products with a GMO label, most participants said yes. Most participants said, that as
consumers they have the right to know about the production process of the food they eat,
and as a result, products produced by biotechnology should be labeled as such. In
addition, participants believed that biotechnology is beneficial, and is a process, that once
they have more information about, would more readily embrace. The focus group
discussion indicated that both logo and text disclosure were important attributes. Location
of the disclosure was also important, and the respondents thought that any easily
identifiable logo would aid their shopping and purchase decisions. Based on these results,
the attributes selected for the mail survey are presented in table 3.1.
Table 3.1 Attributes and Their Levels Used in Survey
Attribute
Levels
Simple text disclosure
Text disclosure with benefits of the technology
No text
Present
Absent
Principal Display Panel
Informational Panel

Text disclosure of biotech
Ingredients
Biotech logo
Location of a Biotech logo

The Experimental Design
The focus-group discussion identified three important attributes and levels, which
were combined to form hypothetical biotech labels. Levels were based on results from the
focus group discussion, and FDA’s labeling requirement guidelines were used to ensure
that realistic scenarios were presented.

Respondents’ evaluation and measurement of
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potential products takes either a metric scale, used for rating, or a non-metric scale used
for ranking.
When rating scales are used, respondents normally grade perceived benefits on
metric scales (Gustafsson et al., 2000). On the other hand, ranking scales only present an
order of preference (i.e. ordinal relationship). Consumers find the rank order approach
easier when only a few products are evaluated. This is because respondents are only
required to say which alternative is preferred over another (Green and Srinivasan, 1978).
The disadvantages of using ranking scales include the inability of respondents to express
indifferences between alternatives, and the difficulty of the ranking task with a large
number of product profiles.
By contrast, rating scales require respondents to provide the intensity of their
choices for competing alternatives (Green and Srinivasan 1978). The main advantage of
using rating scales is the increased information they may contain. Unlike rank scales,
rating scale provide ordinal measures of preferences as well as relative measures. The
absolute measures of preference are contained within the rating scores of each alternative,
while the relative measures can be determined by comparing responses among various
alternatives. Respondents are able to express indifference among alternatives by giving
them identical rating. For this reason, the rating method offers more benefits to the
research, and is likely to be more reliable than the ranking method (Green and Srinivasan,
1978). Boyle et al., (2001) evaluated a comparison of the response formats used in
conjoint analysis. The study found that respondents who used a rating scale provided ties
for their responses, while people who answered the ranking format did not use ties. For
these reasons, the rating format was used in this study.
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After the preference model and measuring scale has been selected, the next step is
to determine the presentation methods.

The two-factor at a time, full profile, and

pairwise comparison methods are most frequently used in conjoint analysis. The twofactor at a time approach requires respondents to compare two attributes at a time and
rank the various combinations of attributes from the most to the least preferred. This
approach is the simplest for respondents, since only two attributes are considered at one
time. It has the advantage of reducing information overload, but its principal
disadvantage is it is limited to ranking data only (Gustafsson, 2000). This approach also
prevents respondents from making realistic choices most commonly used for verbal
descriptions of factor combinations, rather than pictures. (Green and Srinivasan 1978).
Another disadvantage to this approach is its inability to use fractional factorial stimuli to
reduce the number of comparisons (Hair et al., 1998)
An alternative approach, the full-profile method, more closely represents real
buying situations because it utilizes the complete set of attributes. However, this
procedure lends itself to information overload and reduces the accuracy of respondents’
preference evaluation. The number of profiles respondents have to evaluate can be
reduced through the use of fractional factorial designs. For this reason, it is used most
frequently in conjoint analysis. For example, assume you wish to evaluate three
attributes, each with three levels, a total of 27 different product profiles can be evaluated.
This is too large a number of profiles for respondents to effectively rate or rank. Because
of this problem, the full profile procedure is used for relatively small numbers of factors
such as five or six. In many marketing studies, products and services are defined by many
more attributes each a with corresponding large number of levels. The use of a full-
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factorial design becomes impractical since respondents cannot provide meaningful
evaluations when presented with large numbers of treatments. However, various forms of
a fractional factorial designs (split-plot design and confounded factorial design) can be
used to limit the total number of profiles in the analysis.
The third presentation method, the pair-wise comparison method is a combination
of the full factor and the trade-off methods. In this method, profiles normally do not
contain all the attributes as the full-profile, but involve the evaluation of pairs of stimulus
at a time. The pair-wise method is similar to the two factor- at- a-time method except the
pair-wise comparison method compares product profiles and the two factor- at- a- time
method compares individual attributes. A fractional factorial design as prescribed by the
conjoint designer will be used in this study.
Data Collection
Survey Design and Implementation
Methods of data collection are important because they increase the interpretability
and reliability of the study, and strengthen the statistical analysis of the study. Surveys
can be administered by mail, or in person or by telephone. Each has it advantages and
disadvantages. Telephone interviews allow the interviewer to clarify questions that a
respondent may misunderstand, and they have the ability to randomly sample using
random-digit dialing. Telephone interviews are relatively more expensive, compared to
other forms of data collection methods. Another disadvantage of telephone surveys is the
potential for interviewer bias. Interviewer’s bias occurs from the variability in the way
different interviewers communicate with respondents. Another disadvantage of telephone
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interviews is the difficulty for interviewers to hold the attention of respondents for more
than 15 minutes.
The advantages of mail surveys include their relatively low cost, ease of
administration, and geographical flexibility. Pictures and diagrams can also be included
in the questionnaire. The disadvantages of using mail surveys are their characteristically
low response rates, and the need for follow-up surveys to increase response rates. Also,
respondents may interpret some questions incorrectly and as a result, provide incorrect
answers. For this study, a mail survey was used because the conjoint section of the study
required respondents to rank different biotech labeling characteristics.
Questionnaire
A questionnaire was developed which was divided into six sections. They
included a section on consumer awareness and perceptions of biotech foods, (2) questions
on mandatory or voluntary labeling, (3) a conjoint experimental design on labeling
formats, (4) questions on the purchasing of biotech foods, (5) questions regarding the
consumer’s use of food labels, and (6) questions on consumer demographics. A copy of
the questionnaire appears in appendix A.
The first part of the questionnaire provided background information on
biotechnology. It included a definition, the present and future uses (benefits), and
examples of present applications of the technology. This was followed by 12 questions
regarding the respondent’s general knowledge of, and their attitudes toward
biotechnology. Following this introductory section, respondents were asked to choose
between a mandatory labeling or a voluntary labeling policy for biotech foods. A second
question asked respondents to choose the minimum percentage of genetically modified
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ingredients necessary for a product to be labeled. Section six collected information
regarding the demographic and socio-economic characteristics of the respondents.
Questions were asked about age, income, marital status and education.
The conjoint section of the questionnaire was a two-page layout of 7 hypothetical
biotech label formats as prescribed by the fractional design. Respondents were asked to
rate each example of a product with a biotech label. The instructions required respondents
to rate each example (product profile) on a scale from 0 (least preferred) to 10 (most
preferred). Ties were allowed. The labels differ in terms of (1) the use of a biotech label,
(2) location of the biotech label on the package, and (3) the text disclosure on biotech
ingredients.
The survey was administered by mail during the month of July 2002. A modified
version (due to cost considerations) of Dillman’s Mail and Telephone Surveys: The Total
Design Method (1978), was used to guide the survey and the data collection procedures.
Three thousand four hundred and fifty (3450) surveys were mailed to randomly selected
household individuals in Denver, Chicago, Atlanta, Los Angeles, New Orleans, New
York, and Houston.
During the first week of July 2002, each individual was mailed a questionnaire.
The questionnaire was accompanied with a cover letterA, which provided information
about the study. It included a short background introduction to biotechnology and food
labeling, the reason why the study is being conducted, and the importance of the subject’s
response to the success and usefulness of the study. Since a modified version of
Dillman’s Mail and Telephone Surveys: The Total Design Method (1978) was used, the
postcard reminder normally sent during the second week was omitted. Instead, a reminder

A

See Appendix A
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letterA and a follow-up questionnaire were sent two weeks after the initial mailings. The
letter served two purposes, (1) it thanked the individuals who had responded, and (2)
reminded those who had not responded to do so as soon as possible because their
participation are important for success of the study.
One difficulty with mail questionnaires, is that not all respondents will answer all
questions. Sections will be left unanswered resulting in incomplete questionnaires that
cannot be used in the analysis. In addition, surveys will be “ not deliverable” because of
“incorrect addresses”. Responses were received from 524 (15 % of sample) individuals.
However, not all of the returned surveys were completed. Only 509 respondents returned
a completed questionnaire for a 14.75 % useable response rate. Of the initial sample of
3450 surveys, nine were undelivered.
Model Specification
Evaluation and measurement of product profiles in conjoint studies usually
involves using either a metric scale or a non-metric scale to elicit consumer preferences.
Methods that assume the dependent variable is of an ordinal scale are ranked ordered
because they provide a non-metric ordering of respondents’ preferences. The interval
rating method is used when metric measures of respondents’ preferences are obtained.
The ranking format allows respondents to rank product profiles from most preferred to
least preferred. The rating format asks respondents to indicate their preferences for
several hypothetical products, which could results in two or more products receiving the
same score. This ability to express order, indifference and intensity for different product
profiles, allows for both cardinal and ordinal properties of utility to be examined.
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(Harrison et. al., 2002). The type of coding such as ranking or rating also plays an
important part in model selection used for estimation of part-worth values.
Most CA studies use Ordinary Least Square (OLS) or ordered regression models
such as ordered probit and two-limit tobit to measure respondent part worth values.
rating of product profiles. Studies by Harrison et al., 1998, Baker and Crosbie 1993,
Halbrendt, et al., 1991 have used the rating scale method and OLS to estimate
respondents’ part worth values. When analyzing rating preferences in CA, the dependent
variable is usually limited and censored on both ends. If these bounded ratings are
estimated using OLS, the residuals will be truncated and the parameters will be
asymptotically biased (Harrison et al., 2002). The ordered probit and two-limit tobit
models are more appropriate than the OLS in estimating limited dependent variables. The
ordered logit model differs from the ordered probit model only in the cumulative
distribution function that is used to define choice probabilities (Griffiths et al., 1993).
Results from the probit and logit models are usually similar and therefore, there is little
basis for choosing between either model. For this study, because the dependent variable
in the conjoint model is censored and discrete (0 …10,) an ordered probit model is used
to analyze consumers ratings.
Model I
Respondents were presented with 7 hypothetical labeling formats and were asked
to rate each using a interval rating scale from 0 to 10. The label formats had three
attributes; (1) use of biotech logo with three levels, (2) location of the biotech logo on the
package with two level, and (3) the text disclosure of biotech ingredients with two levels.
It was hypothesized that individual preferences for biotech labels may be related to
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demographic characteristics such as education, age income, ethnic origin, and gender. An
ordered probit model is used to estimate consumer preferences for these labeling
attributes which included the demographic variables. The following empirical model was
used:
Rn,i = β0 + β1 X1+ β2 X2 + β3 X3 + β4 X4 + b5EDUij +b6Ageij +b7INCij+ b8RACEij
+b9GENij +εn
where, Rn,i is the nth respondent’s rating (0 –10 scale) of the ith labeling format, bo is the
constant term, and bi represents the part-worth estimates for each of the attributes-levels.
The right hand variables are coded as follows: X1= 1, X2 = 0, if the text disclosure
describes the benefits of biotech ingredients contained in the product; X1= 0, X2= 1 for
simple text disclosure, which states the product contains biotech ingredients, and X1= -1,
X2 = -1 if no text disclosure is present. The logo’s location attribute is coded as follows;
X3 = 1 if the logo appears on the primary display panel (PDP), X3 = -1 if the biotech
logo appears on the information panel (IP); and, X4= 1 if a logo is present and X4= -1 in
if there no logo. EDUij denotes the education levels of the ith individual, where j = 1,2,
…6 for 6 education categories, and EDUij = 1 if respondent ith indicated their education
level falls in the jth category, otherwise EDUij = 0.

INCij reflects the annual yearly

income of the ith individual, where j = 1,2, 3…9 for 9 income categories. INCij = 1 if the
ith respondent indicated their income is in the jth category, otherwise INCij = 0. RACEij
represents the ethnic background of the ith individual, where j = 1,2, …6 for 6 ethnic
background. RACEij = 1 if the ith respondent indicated their race is in the jth category,
otherwise, RACEij = 0. AGEij represents the age group of the ith individual, where j =
1,2, …6 for 6 ages groups, and AGEij = 1 if ith respondent indicated their age is in the jth
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category, otherwise AGEij = 0 and GENij represents the gender of the ith individual,
where j = 1 for two gender categories, and GENij = 1 if the ith respondent is in the jth
category, other wise GENij = 0.
Model II
It is hypothesized that choices between a mandatory versus a voluntary labeling
policy may be affected by respondents’ general perception of biotechnology. The
explanatory variables used in this model were questions 6 through 12 from the mail
survey. The dependent variable was in the binary form, where 1 represents respondents
who agreed with FDA’s voluntary labeling policy and 0 if respondents supported a
mandatory labeling policy. The binary probit model used in the estimation was
Voluntary/Mandatoryi = b0+bq6i+bq7i+bq8i+bq9i+bq10i+bq11i+ bq12i
Where Voluntary/Mandatoryi is the previously defined dependent variable, q6i =
response by the ith individual to question 6 from the questionnaire; q7i = response by the
ith individual to question 7 from the questionnaire; q8i = response by the ith individual to
question 8 from the questionnaire; q9i = response by the ith individual to question 9 from
the questionnaire; q10i = response by the ith individual to question 10 from the
questionnaire; q11i = response by the ith individual to question 11 from the questionnaire;
and q12i = response by the ith

individual to question 12 from the questionnaire.

Responses to questions 6 through 12 are coded as follows: 5 = strongly agree, 4 = agree,
3 = neutral, 2 = disagree and 1= strongly disagree.
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CHAPTER 4
RESULTS
Introduction
This chapter reports and discusses the results from the mail survey that was used
to collect quantitative and descriptive data. The analysis also presents the part-worth
estimates used to determine the attributes’ relative importance in selecting biotech
labels. The general reporting format is as follows: (1) descriptive data, which includes a
discussion of socioeconomic and demographic characteristics of the sample, (2)
summarized respondents’ responses to attitude statements in the survey, (3) results from
the empirical ordered probit and binary models presented in chapter 3 and (4),
discussion and interpretation of model results.
Survey Response Rate
Questionnaires were mailed to 3,450 households in Atlanta, Chicago, Denver,
Los Angeles, New Orleans, New York, and Houston. A total of 509 usable surveys were
returned for an overall response rate of 14.75%. Table 4.1 presents each region’s
response rate, plus the response rate for the overall survey. Denver, Colorado provided
the highest response rate of 20%, followed by New Orleans (18%) and Chicago (17%).
Respondents from New York returned the lowest response rate of 8.6%.
Table 4.1 Response Rates of Survey Respondents for the Seven Metropolitan
Regions Used in the Study.
Number of Surveys
Number of Surveys
Region
Response Rate
Mail
Returned
Denver
500
100
20.0
New Orleans
500
92
18.40
Chicago
500
85
17.00
Los Angeles
500
71
14.20
Atlanta
450
61
13.56
Houston
500
57
11.40
New York
500
43
8.60
Total
3450
509
14.75
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Descriptive Statistics of Sample
Table 4.2 presents summary statistics for demographic information about
respondents. Of the 509 respondents, 274 or (54%) were males and 235 (46%) were
females. All age groups were represented in the sample, with the 45-54 age group
accounting for the most responses, 27% of sample. Hence, the median age of the sample
was between age group 45-54. Respondents were well educated as over three quarters
(8o%) had completed some college courses, graduated with a bachelor degree, or had
done post graduate work. The median annual income of respondents was between
$30,000-$44,999, which accounts for 20% of the sample. Six percent had annual income
of less than $15,000, and 10% of respondents made in excess of $120,000 in yearly
earnings.
Consumer Awareness and Perceptions of Biotech Foods
The study found that awareness i.e, having read or heard of biotechnology foods
was higher among U.S. consumers when compared to previous studies. For instance,
Hoban and Kendall (1992) conducted a survey on consumer awareness of biotechnology
and found that 48 % of respondents were aware of biotechnology. The Wirthlin Group
Quorum Survey (1999) also did a study on awareness and reported a 20% awareness
level by respondents. Table 4.3 and figure 4.1 summarizes the percentage of awareness
of respondents, and their levels of awareness. Eighty four percent of the respondents
have heard about biotech foods, while only 16 % said they have not read or heard
anything about biotech foods. Of the 84 % of respondents who indicated they are aware
of biotech food, 60 % indicated they believed themselves to be either very informed
(3.5%), moderately informed (23.8 %) or somewhat (32.4%) informed about
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biotechnology (figure 4.1). The remaining 36% having heard of biotech foods said they
believed themselves to be only minimally informed about biotechnology.

Table 4.2 Frequency Distribution of Socio-Demographic Characteristics of Survey
Respondents of Biotech Labeling Survey
Demographic Characteristics
Number
Percentage
Sample (n= 509)
Gender
Male
274
54.0
Female
235
46.0
Age (years)
18-24
25-34
35-44
45-54
55-65
65 or older

12
56
99
135
93
114

2.36
11.00
19.45
26.52
18.27
22.40

Education
Less than high school
Completed High school
Technical school
Some college
Completed bachelor degree
Post graduate work

2
58
37
119
150
143

0.39
11.39
7.27
23.88
29.47
28.09

Income
Less than $15,000
$15,000 -$29,000
$30,000 - $44,999
$45,000 - $59,999
$60,000 -$74,999
$75,000 -$89,999
$90,000 -$104,999
$105,000 -$119,999
More than $120,000

33
47
101
99
76
53
32
19
49

6.48
9.23
19.84
19.45
14.93
10.41
6.29
3.73
9.63

43

Table 4.3 Respondents’ Awareness Level of Biotechnology
Number of Respondents
Aware of biotechnology
Not aware of
biotechnology

Percentage of Respondents

429

84 %

80

16 %

40.0

35.9
32.4

35.0

30.0

Percent of Respondents

23.8
25.0

20.0

15.0

10.0

4.4
3.5

5.0

0.0
Very informed

Moderately informed

Somewhat informed

Minimally informed

Not at all informed

Level of Awareness

Figure 4.1 Percentage of Respondents indicating levels of Awareness.
Before looking at the ordered probit model presented in chapter 3, table 4.4
provides cross-tabulations of the relationship between general consumer awareness and
demographic factors. Of the 84 % of respondents who are aware of biotechnology, 58%
were male and 42% were females. Further analysis of the data showed that respondents
within the age groups 35-44, 45-54 and the 65s and older, were more aware of
biotechnology than other age groups. Respondents in these age groups indicated a
21.21%, 27.51% and 21.68% level of awareness respectively. The demographic variable
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education showed more of an influence than any other variable. Respondents who had a
bachelor degree (31%), or those who had completed postgraduate work (31.93%),
indicated greater awareness of biotechnology than other respondents. Hence, more
educated individuals considered themselves to be more informed about biotechnology
than less educated respondents. The effect of gender on awareness was also interesting.
In general, men considered themselves more aware about biotechnology than females.
Fifty eight percent of males said they were aware of biotechnology compared to forty
two percent of females.
Table 4.4 Cross Tabulation of Awareness Level and Socio-Economic Demographic
Make-up of Sample.
% Total
Percentage Level of Awareness
Response
Aware

Very
Informed

Moderately
Informed

Somewhat
Informed

Minimally
Informed

Not
at all

Gender
Male
Female

58.04a
41.96

1.63b
3.03

20.75
15.15

18.18
13.99

15.15
8.62

2.33
1.17

Age (years)
18-24
25-34
35-44
45-54
55-65
65 or older

2.10
9.32
21.21
27.51
18.18
21.68

0.00
0.93
0.70
0.70
0.93
1.40

1.17
2.10
10.49
8.39
5.83
7.93

0.70
3.73
4.43
10.49
7.23
5.83

0.23
2.10
5.13
6.99
3.26
6.06

0.00
0.47
0.47
1.17
0.93
0.47

Education
Less than high school 0.00
0.00
0.00
0.00
0.00
0.00
High school
8.86
1.86
3.96
1.17
1.63
0.23
Technical school
7.69
0.23
3.03
4.20
0.23
0.00
Some college
20.51
1.17
10.49
4.90
3.50
0.47
Bachelor degree
31.00
0.93
11.19
10.02
8.16
0.70
Post graduate work
31.93
0.47
7.23
12.12
10.26
2.10
a
- Vales in the table are the percentage of total responses for awareness of the sample.
b
- Values in the tables are the percentage of total responses indicating each level of biotech
awareness

Figure 4.2 shows the percent of respondents indicating the most familiar
biotechnology term. Fifty two percent of those surveyed indicated that genetically
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engineered foods was the most familiar term associated with biotechnology while the
least familiar term was bioengineered food, (6%). Genetically modified foods (22%)
and biotech foods (13%), were the second and third most familiar terms respectively. Of
the 429 respondents who said they were aware of biotechnology, 37 % said they know
that foods produced through biotechnology are presently in their local supermarket or
grocery store. Moreover, of the respondents who considered themselves more informed,
all answered yes when asked if there are any foods produced through biotechnology in
their local supermarket. They identified vegetables (114), tomatoes (100), corn (98), and
cereal/grains (86) as the leading foods in supermarkets known to be made from
biotechnology. See Figure 4.3 for the complete list.

Bioengineered foods
6%
Genetically modified
organism (GMO) - GMO food
7%

Genetically modified foods
(GM)
22%

Biotech foods
13%

Genetically engineered foods
(GE)
52%

Figure 4.2 Percent of Respondents Indicating the Most Familiar Biotechnology Term

.

46

20

67

Meats 64

Potatoes 56

40

Processed Foods

Milk/Dairy

72

Fruits 86

Cereal/Grains 86

60

Corn 98

80

Tomatoes 100

100

Vegetables 114

Number of Respondents

120

0
Types of Food

Figure 4.3 Number and Kinds of Food Identified by Respondents As
Being Produced By Biotechnology in Their Local Supermarket.
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Consumer Perception of Biotechnology
As table 4.5 shows, 41.25% of respondents either strongly agree (7.07%) or
agree (34.18%) that biotech foods are reasonably safe for human consumption. On the
other hand, 17.28% of respondents think that genetically engineered food products are
not reasonably safe for human consumption. Forty one percent of the respondents
remained neutral when answering this question. In terms of the effect of biotech crops
on wildlife and the environment, 40% agreed that these type crops may have an adverse
effect. Eighteen percent disagreed. A quarter (25%) of the survey respondents thought
that meat products produced from biotechnology pose more health risks than foods made
from biotech crops. Half of the respondents remained neutral in answering this question.
There was support for biotechnology from respondents as more than 50% thought
biotechnology benefits society because it allows farmers to produce food more
efficiently. Only 16% thought there were no benefits from biotechnology to society.
However, concerns about food products still exist. Labeling of these types products is
the major issue. To respondents, food labels indicating the presence of biotech
ingredients are very important because 81 % indicated that food products should have
biotech labels, whereas only 6% weren’t in favor of biotech labels. According to this
sample of respondents, the approval of biotech food products by the FDA for
consumption, does not necessarily mean the consumers will accept the product. Fifty six
percent indicated that FDA’s approval of biotech foods does not equate to biotech food
products being safe.
Mandatory or Voluntary Labeling
The present policy of the FDA is that labeling of biotech foods should be
voluntary since it has been determined these foods have the same safety and nutritional
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Table 4.5 Respondents’ Perceptions and Attitudes Of Biotechnology
Strongly
Agree

Agree

Neutral

Disagree

Strongly
Disagree

percent
Question 6.

Biotech Foods are reasonably safe for human
consumption.

7.07

34.18

41.45

11.39

5.89

Question 7.

Biotech crops may have adverse effects on wildlife
and the environment.

10.81

29.08

41.85

15.32

2.75

4.13

20.43

53.05

19.06

3.34

11.00

42.63

30.45

10.81

5.11

3.34

19.45

20.83

31.04

24.75

Question 8.

Meat products produced using biotechnology are
more likely to pose health risks than foods made
from biotech crops.
Question 9. Biotechnology benefits society because it allows
farmers to produce food more efficiently.
Question 10. There is no need to be concerned about the safety of biotech
foods because the U.S. Food and Drug Administration (FDA)
would not let these products be sold in supermarket if they
were not safe.
Question 11.

Foods labels are needed to show the presence of biotech
ingredients, since consumers could face unknown health risks.

40.86

40.67

12.57

4.91

0.98

Question 12.

It is unethical to produce a food using biotechnology.

4.72

8.45

36.54

29.86

20.24
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content as other foods. FDA argues that mandatory labeling of biotech foods could
unnecessarily raise the health concerns about biotech foods. However, critics of this
policy say that any food produced through biotechnology should be labeled, even if the
safety aspect of the food has not changed. Survey respondents were asked to choose
between the present FDA’s policy of voluntary labeling or the mandatory labeling of
biotech foods as argued by critics of the FDA’s policy. Of the 509 respondents, 409 or
80% of the sample were in favor of a mandatory labeling policy for biotech food
products. Only 20% of the respondents indicated they agreed with FDA’s voluntary
labeling policy, despite being informed of FDA’s concern that mandatory labeling would
unnecessarily raise heath concerns among consumers, (Table 4.6).
Table 4.6 Respondent’s Responses to a Mandatory or Voluntary
Labeling Policy.
Number of Respondents

Percentage of Respondents

Voluntary Labeling

103

20

Mandatory Labeling

406

80

If respondents were in agreement with the critics’ mandatory labeling policy, a
follow-up question was asked to determine what levels of biotech ingredient contents
warrants labeling. The categories by percentages of biotech ingredients that must be
present were set at the following levels: 50%, 25%, 10%, 5% and any trace. Of the 80 %
of respondents who said that mandatory labeling was preferred to voluntary labeling, 67.5
% indicated that labeling should be mandatory if a food product contained any trace of
ingredients produced with biotechnology. Another 13.8% said that mandatory labeling
should be required only if more than five percent of the product’s ingredients are
produced with biotechnology. 6.2 % said mandatory labeling of a biotech product is only
50

necessary when either 25% or 50% of the product has been genetically modified (figure
4.4)

300

274

Number of Respondents

250

200

150

100
67.5%
56
50

25

25

26
6.2.%

6.2%

13.8%

6.4%

0
50% of product's
ingredients

25% of product's
ingredients

10% of product's
ingredients

5% of product's
ingredients

Any trace of product's
ingredients

Threshold Levels

Figure 4.4 Number and Percentage of Respondents Indicating the Minimum Levels
of Biotech Ingredients that Warrant Mandatory Labeling.
Purchase of Biotech Foods
Differences existed between consumers who are willing to purchase a meat
product made from biotechnology compared to a non-meat food product. Respondents
were asked, would you purchase a non-meat food product that has been produced using
biotechnology? The responses to this question fell into three categories; yes (46%), no
(16%) and those that were uncertain (38%). However, when the same question was asked
in regards to a meat product, the responses changed to; yes (24%), no (32%), and
uncertain (44%). A combined 54% would not or were uncertain about purchasing a non-
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meat bioengineered food product, while more than three quarters (76%) of the sample
would not or were uncertain about purchasing a meat product made from biotechnology.
Figure 4.5 displays the percentage responses of survey participants on purchasing both
types of biotech foods products.

44%
Uncertain

38%

32%
No

16%

24%
Yes

46%

W ould you purchase a m eat product m ade from
biotechnology?

W ould you purchase a non-m eat food product
m ade from biotechnology?

Figure 4.5 Respondent’s Choices on Purchasing a Non-meat versus Meat Product
Made From Biotechnology.

Consumer Use of Food Labels
This section of the questionnaire contained four questions pertaining to the
frequency with which consumers read food labels when buying a product. Table 4.7
shows that consumers on average read both nutritional information and ingredients lists
when buying either familiar or new products. The first two questions asked if respondents
read the nutritional and ingredients sections of food labels before buying a familiar
product. Thirty seven percent of the respondents indicated they read the nutritional
section of food labels often, and 31% indicated they sometimes read the nutritional
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section of food labels before buying a familiar product. Only 14% said they always read
the nutritional section of food labels when buying a familiar product. Results were almost
similar for consumers when asked how often they read the ingredients section of food
labels of familiar products.
The next two questions asked if respondents read the nutritional and ingredient
sections of food labels before purchasing a new product. Forty percent of the respondents
indicated that they always read both nutrition and ingredients labels when purchasing a
product for the first time, while 55% said they either sometimes or often read nutrition
labels the first time they buy a new food product. Also, 53 % of the respondents said they
read the ingredient section of food labels either often or sometimes when buying a new
product. Only 2% of respondents said they never read foods labels before purchasing new
food products. Two important findings emerge from the analysis of consumer use of food
labels. The first is that that consumers place equal importance on the knowledge gained,
or information provided by both the nutritional and ingredients lists. The second and most
significant is that consumers place greater emphasis on labeling when purchasing new
food products.
Table 4.7 Percentage of Respondents Indicating their Use of Food Labels
Always

Often Sometimes

Rarely

Never

Percent
Quest 17. How often do you read the
nutritional section of food labels
before buying a familiar product.
Quest.18. How often do you read the
ingredients section of food labels
before buying a familiar product.
Quest. 19. How often do you read the
nutritional section of food labels
before buying a new product.
Quest. 20. How often do you read the
ingredients section of food labels
before buying a new product.

53

14

37

31

16

2

11

33

32

21

3

40

41

14

4

1

40

38

15

6

1

Conjoint Model Results
Conjoint analysis begins with the estimation of the part-worth utilities for the total
sample. This entails examining the part-worth coefficients, as the size and sign indicate
the degree and direction in which respondents prefer a particular level of an attribute. The
constant term in the model is the overall mean preference rating of biotech labeling
formats. The part-worth values for the attribute levels of a given label are then added to
the constant term to determine total utility for a particular label format.
Recall from chapter 3 that each attribute level has a dummy code associated with
it to determine the part-worth utility. For example, the attribute logo location is coded as
1, and –1. The coefficients obtained for these variables are then multiplied by the coding
variables to yield the part-worth estimate. Table 4.8 presents the results of the ordered
probit part worth estimates for conjoint analysis of biotech labeling formats.
The chi-square test showed that the overall model was significant at the 1% level.
A t-test was used to test the null hypothesis that the part-worth estimates are equal to
zero. The estimated coefficients for all attribute levels were significant at the 1% level of
confidence. The relatively large positive coefficient for the “text disclosure that describes
the benefits of the biotech ingredients” suggests that this type of disclosure increases the
average respondent’s preferences for biotech labels. The presence of this attribute will
increase utility with a part-worth value of 0.58. A “simple biotech text disclosure” causes
a reduction in part-worth utility as indicated by the negative 0.22 coefficient. This
suggests that consumers in general want more information, and even a simple text
disclosure would not add to consumer utility. The attribute, “presence of a biotech tech
logo” had the second largest positive coefficient of 0.56. In general, the presence of a
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biotech logo increases the average consumer’s overall preference for biotech labeling.
The location of the logo had the lowest effect on respondents’ utility. However, when the
logo appears on the Principal Display Panel (PDP), as opposed to the Informational Panel
(IP), the average consumer’s preference for labeling increased as indicated by the
positive 0.12. The ‘no text’ attribute decreased overall preference and utility by .36 which
suggests that absence of a text disclosure decreases the average respondent preference for
biotech labels.
To aid in the interpretation of the effects of individual characteristics on biotech
label preferences, several demographic variables were included in the model. The sociodemograhic characteristics used were age, education, annual income, gender, and race.
The estimates for the education variables are positive but not significant at either
the 1% or 5% levels of confidence. However, respondents having a bachelor degree were
significantly different from the post graduate category at the 10 percent level, which
indicates that these individuals have greater preferences for biotech labels compared to
individuals with the highest education in the sample. Two of the age dummy variables
are significant at the 10 percent level. The coefficient for the 65 and older is positive and
significant at the 5% level. Similarly, the 55-65 age group is positive and significant at
the 10% level. The results imply that respondents older than 55 years of age have a
greater preference for biotech labeling relative to the omitted age group (45-54). Most of
the income dummy variables are not significant. However the $15,000 - $29,000 group,
and the more than $120,000 group, coefficients are negative and significant at the 5% or
better level. This means that each of these categories preferences, for biotech labels is
lower relative to the $30,000 to $44,999 income level.
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Table 4.8 Ordered Probit Part Worth Estimates for Conjoint Analysis of Biotech
Labeling Formats in Combination with Demographic.
Standard
Variable
Coefficient
(t-ratio) P-Value
Error
Constant
1.207***
0.151
7.961
0.000
Text disclosure that describes the
0.575***
0.037
15.255
0.000
benefits of biotech ingredients
Simple biotech text disclosure
-0.218***
0.039
-5.522
0.000
No Text
-0.357***
0.049
-7.262
0.000
Biotech logo appears on the PDP
0.122***
0.030
4.029
0.001
Presence or absence of a biotech logo
0.557***
0.033
17.074
0.000
Gendera
Female
0.012
0.051
0.241
0.809
b
Education
Completed high school
0.083
0.097
0.856
0.392
Technical college
0.042
0.099
0.422
0.673
Some college
0.064
0.073
0.886
0.376
Bachelor degree
0.119*
0.071
1.684
0.092

Incomec

Less than $15,000
$15,000 - $29,999
$45,000 - $59,999
$60,000 -$74,999
$75,000 -$89,999
$90,000 -$104,999
$105,000 -$119,999
More than $120,000
Aged
18-24
25-34
35-44
55-65
65 or older
Racee
White
African American
American Indian
Hispanic
Other

-0.191
-0.258***
-0.244***
-0.121
-0.041
-0.074
-0.014
-0.282**

0.127
0.094
0.081
0.088
0.094
0.113
0.133
0.119

-1.510
-2.746
-3.019
-1.383
-0.441
-0.657
-0.104
-2.364

0.131
0.006
0.003
0.167
0.659
0.511
0.917
0.018

0.135
0.026
0.101
0.124*
0.172**

0.161
0.096
0.075
0.069
0.078

0.834
0.271
1.396
1.813
2.197

0.405
0.786
0.163
0.069
0.028

-0.229*
-0.255
-0.139
-0.237
-0.203

0.132
0.176
0.394
0.167
0.180

-1.743
-1.447
-0.353
-1.415
-1.125

0.081
0.148
0.724
0.157
0.260

*** Indicates estimated coefficient is significant at the .01 level ; c2 Log-L -4150.94
** Indicates estimated coefficient is significant at the .05 level; Chi-square = 777.28, p-v. 0.00
* Indicates estimated coefficient is significant at the .10 level ; N=509*7= 3,563
a
Excludes the gender male.
b
Excludes the post graduate work category ; the less than high school group was omitted
from the analysis because only two responses were in this education category.
c
Excludes the $30,000 - $44,999 income category
d
Excludes the 45 –54 age group category
e

Excludes the Asian category.

56

In regard to ethnic background, all estimated coefficients were negative and are
not significant except for the category for whites, which was significant at the 10%
levels. Results would suggest that Asians (the omitted category) are more likely to prefer
labeling of food products produced from biotechnology relative to whites. Gender had no
effect on respondents’ preferences for a biotech labels.
Relative Importance of Attributes
The relative importance of product attributes was calculated using the part-worth
utility values from the ordered probit model. To determine the relative importance of an
attribute, each attribute’s highest and lowest part-worth utilities are utilized. The
difference between the highest and lowest part-worth values establishes the utility range
for the given attribute. Once the utility range for all attributes is determined, the relative
importance of each attribute is calculated by dividing the utility range for the attribute by
the sum of all attributes. (Harrison et al., 1998). The equation used is,
é

ù

RIi = êêë Utility Rangei ¸ å utility ranges " attributesúúû ´ 100
where RII is the relative importance for the ith attribute. The results presented in table 4.9
indicate that the most important attribute was the presence of a logo, contributing 48.7 %
to the preference rating. The text disclosure that describes the benefits of the biotech
ingredient was determined to be the second most relevant attribute, accounting for
40.87% of the preference rating. The third most important attribute contributing 10.43%,
was the location of the logo on the product package.
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Table 4.9 Relative Importance of Attributes For Biotech Label

Attribute

Relative Importance (%)

Text disclosure

40.87

Location of logo

10.43

Presence of a biotech logo

48.70

Model II
It is hypothesized that choices between a mandatory versus a voluntary labeling
policy may be affected by respondents’ general perceptions and attitudes of
biotechnology. In addition, respondents’ perceived level of risks and benefits associated
with biotechnology, may also influence acceptance of either labeling policy. Recall from
chapter 3 that the explanatory variables used in this model were questions 6 through 12
from the mail questionnaire. Resulting opinions for these questions were expressed as
ranging from 5 (strongly agree) to 1 (strongly disagree). A key assumption is that a 5 to 1
coding represents an ordered scale of respondent’s opinion regarding each statement. The
dependent variable was in binary form, where 1, represents respondents who agreed with
FDA’s voluntary labeling policy, and 0, if respondents supported a mandatory labeling
policy. The index function coefficients and marginal probabilities for mandatory versus
voluntary biotech labeling are presented in table 4.10.
The chi-square test showed that the overall model was significant at the 1
significance level. Coefficients on questions 7, 10 and 11 are significant at the 1
significance level. All other coefficients are not significant. Question 7 has a negative
coefficient indicating that as respondents’ level of agreement with the statement that
biotech crops may harm the environment and wildlife increases, they are more likely to
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support a mandatory labeling policy. The marginal effect on this variable indicates as
respondents’ perception that biotechnology is harmful to the environment and wildlife
increases, the probability of them supporting a voluntary labeling policy, decreases by
.052. Question 10, which ask respondents if approval of biotech food products by the
FDA as an inspection and regulatory agency means the product is safe for consumption,
has a positive coefficient. Hence, if consumers believe this to be true, they are more
likely to support a voluntary labeling policy. The marginal effect indicates that if
respondents trust the FDA inspection and safeguard regulations regarding biotech foods,
the probability of them agreeing with FDA’s voluntary labeling policy increases by
0.059. Question 11 has a negative coefficient, which indicates that as a respondent’s
perception of unknown health risks associated with biotech foods increases, they are
more likely to support a mandatory labeling policy. The marginal effect show that the
probability of these respondents agreeing with a mandatory labeling policy will increase
by .095.
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Table 4.10 Binary Probit Coefficients and Marginal Probabilities For Mandatory Versus Voluntary Biotech labeling.
Equation
Variable

Constant Term
Q6.

(tratio)

P-Value

Coefficient

Standard
Error

0.693

-0.021

0. 983

-0.003

0.129

1.545

0.122

0.093

-2.486

0.103

Coefficient

Standard
Error

-.1042

Biotech Foods are reasonably safe for
0.199
human consumption.
Q7.
Biotech crops may have adverse effects
-0.230**
on wildlife and the environment.
Q8.
Meat products produced using
biotechnology are more likely to pose
0.131
health risks than foods made from
biotech crops.
Q9.
Biotechnology benefits society because it
-0.022
allows farmers to produce food more
efficiently.
Q10. There is no need to be concerned about the
safety of biotech foods because the U.S.
0.259***
Food and Drug Administration (FDA)
would not let these products be sold in
supermarket if they were not safe.
Q11. Foods labels are needed to show the
presence of biotech ingredients, since
-0.418***
consumers could face unknown health
risks.
Q12. It is unethical to produce a food using
-0.061
biotechnology.
* Indicates estimated coefficient is significant at the .10 level
** Indicates estimated coefficient is significant at the .05 level
*** Indicates estimated coefficient is significant at the .01 level
N = 507
Chi-square = 101.6740; c 2 Log-L-205.522

Marginal Effects
(tratio)

PValue

0.157

-0.021

0.983

0.045

0.029

1.535

0.119

0.012

-0.052**

0.020

-2.535

0.011

1.265

0.206

0.029

0.023

1.276

0.202

0.118

-0.186

0.852

-0.005

0.027

-0.186

0.852

0.071

3.669

0.002

0.059***

0.016

3.749

0.000

0.085

-4.902

0.000

-0.095***

0.019

-4.816

0.000

0.093

-0.656

0.5111

-0.014

0.021

-0.658

0.510
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CHAPTER 5
SUMMARY AND CONCLUSIONS
Today’s consumers are placing increasing importance on food quality, food safety
and the environment. As a result, the production and marketing of genetically modified
foods have caused some concern among certain consumer groups. Consumer acceptance
of genetically modified foods has varied because of different attitudes toward the health
and environmental risks associated with these products.
Intricately linked to the debate on agriculture food biotechnology is the matter of
labeling and information. Economics and marketing studies on the value of information
have characterized information on food labels as reducing consumer’s uncertainty
regarding safety and nutritional qualities of food. Labels serve as a source of information,
and for labels to achieve their objectives, consumers must understand the information
provided by labels.

This study has explored the relationship between information and

labels, and consumers’ perceptions of agricultural biotechnology.
The overall objectives were to: (1) measure consumer attitudes and perceptions
toward foods produced using biotechnology, (2) quantify labeling preferences regarding
biotech foods, and (3) determine the frequency of consumers’ use of food labels in
general to accomplish these objectives a questionnaire was developed.
The survey consisted of questions on respondents’ perceptions and attitudes to
biotechnology, consumer use of food labels, and conjoint analysis questions. The first
section asked respondents to indicate their level of awareness and perceptions on biotech
foods. Eighty four percent of the respondents indicated they have heard about biotech
foods, while 16% said they have not read or heard anything about biotech foods. Previous
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researche conducted in 1997 and 1999 found awareness levels to be 20 and 40%,
respectively. Fifty two percent of those surveyed indicated that genetically engineered
foods was the most familiar term associated with biotechnology, while the least familiar
term was bioengineered food, (6%). One primary reason for this increased level of
awareness is media coverage. In recent years, the media has focused a lot on
biotechnology, even sensationalizing some stories as “dolly” the sheep, the Bovine
Spongiform Encephalopathy (BSE) crisis in England, and the genetically modified
“STARLINK corn” found in Kraft’s taco shells which contamination the food supply,
and its subsequent recall in the U.S.
Respondents were asked about their general perception about biotechnology,
41.25% of the respondents thought that biotech foods were reasonably safe for human
consumption. More than half of the respondents viewed biotechnology as beneficial
because it allows farmers to produce food more efficiently. Respondents, although
supportive of biotechnology, still exhibited some concerns about the technology. Eighty
one percent were strongly in favor of biotech labeling. More than three-quarters of the
surveyed respondents indicated that they supported a mandatory labeling policy for
biotech foods. In addition, 67% indicated that labeling should be mandatory if a food
product contained any trace of ingredients produced with biotechnology.

Despite

consumers’ concerns about the risks associated with genetically modified food products,
respondents were still willing to purchase these type products. The only notable
differences in respondents’ willingness to purchase biotech foods, is that respondents
were more likely to purchase a non-meat biotech food compared to a meat product
produced from biotechnology.
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In terms of consumer usage of food labels, an important finding was that
consumers place greater emphasis on labels of new products compared to those of
familiar products. They were twice as likely to read both the ingredients list and nutrition
information on new product labels. This is an significant finding since biotech foods are
considered new products by many consumers. There was no substantial evidence from
the study to show that differences in socio-demographic factors contribute to consumer
usage of food labels.
Statistical Results
In order to estimate the relative empirical importance of labeling of biotech foods,
conjoint analysis was used to determine how respondents with different demographic
characteristics rate different labeling formats. Conjoint analysis provides the means to
determine which labeling characteristics contribute positively or negatively to
respondents’ total preferences of biotech labels.
An ordered probit regression analysis was used to estimate the rating on the 7
hypothetical biotech labeled products. The product profiles receiving the highest rating
was “product A” (appendix A) which had the attributes, text disclosure with benefits and
a biotech logo located on the PDP. The attribute found to be more significant in providing
utility to respondents was a text disclosure with benefits and the presence of a biotech
logo. This was evident in the significance of the parameter estimates. The relative
importance of both attributes were 40.87% and 48.70%, respectively. Results suggest that
respondents have definitive preferences for biotech labels, and in general need more
information on food labels. The results of the conjoint analysis indicates that on the
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whole, differences in education, age, income and race weren’t significant determinants in
determining respondents preferences for biotech labels.
The second model in the study examined consumers’ choice for a mandatory
versus a voluntary labeling policy of biotech foods. Respondents who have significant
food safety concerns, or thought there unknown health risk associate with biotechnology,
or believe that genetically modified products may harm the environment, were in favor of
a mandatory labeling policy. Dissatisfaction with a voluntary labeling policy was also a
function of respondents’ lack of confidence in FDA’s assurances that biotech food
products are safe consequently, respondents were more likely to support a mandatory
labeling policy. Moreover, potential support for biotech foods is substantial as almost half
(46%) of the respondents indicated that they would be willing to buy these types
products. Perhaps the most significant finding of this study is that consumers are
genetically receptive of biotechnology, given they are informed about the presence of
biotech ingredients in their foods.
Implications
Several important findings emerge from the analysis of the determinants of
consumer attitudes towards biotechnology and the labeling of these type products.
Consumers in general do use food labels as a source of information when purchasing
food products, and labels play even greater roles when consumers are buying new
products. Therefore, biotech foods, which essentially are new products, need to be
labeled for consumers to willingly purchase them. Results from the focus groups, surveys
questions and respondents comments would suggest some level of uncertainty about
biotechnology. Uncertainties that will no doubt influence respondents’ choice for a
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mandatory labeling policy. Labeling therefore plays a very useful role in reducing some
of this uncertainty. Educational program could also play n important role in consumer
acceptance of biotech food. Promotional efforts from food processors should also focus
on the beneficial aspects of biotech food products. Consumers appeared to have low
levels of confidence in FDA’s food inspection and approval programs. As a result, the
FDA could provide more information to the public on their inspection and approval
procedures, which may help to alleviate some uncertainty and increase consumer
confidence.
Limitations and Future Research
Although a national survey was conducted, only the 7 largest metropolitan regions
were surveyed. The attitudes and perceptions of these respondents may not be the same
for other regions. Another limitation of this study was that most respondents had high
levels of education, a demographic factor that may influence respondents’ choices. Future
research could focus on using larger samples of a more diverse section of the population.
Future extension to this research could also focus on measuring consumers’ willingness
to pay for biotech labels.
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APPENDIX A
QUESTIONNAIRE AND COVER LETTERS
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·

Please complete the questionnaire and return it in the postage-paid return envelope.

·

Your answers are completely confidential. Do not write your name on the questionnaire.

Thank you for your help. We hope you will take part and let your views be represented.

BACKGROUND
Certain food products are being developed or modified by new scientific techniques such as biotechnology or genetic
engineering. Biotechnology involves taking the genes from one species and inserting them in another to transfer a desired
trait or characteristic. Biotech crops can resist diseases, are protected from insect damage, and require less pesticide use, all of
which potentially aid farmers and consumers. Biotech foods also provide consumers with improved nutritional qualities, or
other specialty traits, such as shape, size, freshness and wholesomeness. The purpose of this survey is to determine your
preferences regarding the labeling of these types of products.

Section I: Consumer Awareness and Perceptions of Biotech Foods

1.

Have you read or heard about the use of biotechnology, genetically engineered (GE), genetically modified (GM),
genetically modified organism (GMO) or bioengineered ingredients in the production of food?
a) Yes, I have read or heard about biotech foods.
b) No, I have not read or heard anything about biotech foods.

If your answer to question 1 was (a), please answer questions 2 through 5. Otherwise go to question 6.
2.

Using a 5 point scale, how well informed would you say you are about biotechnology, where one means you are
not at all informed and 5 means you are very informed. (Please circle your response)
a)
b)
c)
d)
e)

3.

- very informed
- moderately informed
- somewhat informed
- minimally informed
- not at all informed

Which of the following terms are you most familiar with? (Circle one)
a)
b)
c)
d)
e)

4.

5
4
3
2
1

Biotech foods
Genetically engineered foods (GE)
Genetically modified foods (GM)
Genetically modified organism (GMO) – GMO foods
Bioengineered foods

Are there any foods produced through biotechnology in your local supermarket or grocery store? (Circle one)
a) Yes

5.

b) No

c) Don’t know

If answered yes, which foods? (Circle all you know)
a) Vegetables
b) Tomatoes
c) Fruits

d) Meats
e) Milk/Dairy
f) Cereals/Grains
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g) Corn
h) Potatoes
i) Processed foods

Please read the following statements carefully, then circle the response that most nearly reflects your opinion.
SA = Strongly Agree,

A = Agree,

N = Neutral,

D = Disagree,

SD = Strongly Disagree

6.

Biotech foods are reasonably safe for human consumption…………….………………….. SA

A

N

D

SD

7.

Biotech crops may have adverse effects on wildlife and the environment………..…….….. SA

A

N

D

SD

8.

Meat products produced using biotechnology are more likely to pose health risks than
foods made from biotech crops…………………………………………….……….…….…SA

A

N

D

SD

Biotechnology benefits society because it allows farmers to produce food
more efficiently………………………………………………………………………. SA

A

N

D

SD

There is no need to be concerned about the safety of biotech foods because the
U.S. Food and Drug Administration (FDA) would not let these products be sold
in supermarkets if they were not safe…………………………………………...………..… SA

A

N

D

SD

Food labels are needed to show the presence of biotech ingredients, since consumers
could face unknown health risks………………………………….…………………………SA

A

N

D

SD

It is unethical to produce a food using biotechnology……………………………………….SA

A

N

D

SD

9.

10.

11.
12.

SECTION II: Mandatory or Voluntary Labeling
The present policy of the U.S. Food and Drug Administration (FDA) is that labeling of biotech foods should be
voluntary, since it has been determined these foods have the same safety and nutritional contents as other foods.
FDA argues that mandatory labeling of biotech foods could unnecessarily raise the health concerns about biotech
foods. However, critics of this policy say that any food produced through biotechnology should be labeled, even if
the safety aspect of the food has not been altered. They argue it is the consumer’s right to know.
13.

Which labeling policy are you most likely to agree with, the FDA’s or its critics?
a) FDA- voluntary labeling of biotech foods
b) Critics – mandatory labeling of biotech foods

If your answer to question 13 was (b), please answer question 14. Otherwise, go directly to section III
14.

Mandatory labeling of biotech foods should be
a)
b)
c)
d)
e)

required only if more than 50% of the product’s ingredients are produced with biotechnology.
required only if more than 25% of the product’s ingredients are produced with biotechnology.
required only if more than 10% of the product’s ingredients are produced with biotechnology.
required only if more than 5% of the product’s ingredients are produced with biotechnology.
required if they contain any trace of ingredients produced with biotechnology.
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SECTION III: Labeling Formats
The following diagrams show different labeling formats for labeling biotech foods. The labels differ in terms of (1) the use
of a biotech logo, (2) location of the biotech label on the package, and (3) the text disclosure of biotech ingredients. Please
rate each example, where 10 is the most preferred and 0 the least preferred. Ties are okay.

(A) Logo on the front and the following text inserted in the ingredients list.

This product contains soybean oil developed using biotechnology
to decrease the amount of saturated fat.

(B) No logo, but the following inserted in the ingredients list

This product contains soybean oil developed using biotechnology
to decrease the amount of saturated fat.

Biotech logo

Rating___________

Rating___________

(C) No Biotech Label

(D) Logo on the front only

Biotech logo

Rating___________

Rating___________
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(F) logo on the side and the following inserted in the ingredient’s list.

(E) No logo but the following inserted in the ingredient’s list.

Contains ingredients derived using biotechnology

Contains ingredients derived using biotechnology

Biotech logo

Rating____________

Rating____________

(G) logo on the front and the following inserted in the ingredient’s list.

Contains ingredients derived using biotechnology

Biotech logo

Rating___________
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SECTION IV: Purchase of Biotech foods

15.

Would you purchase a non-meat food product (example slow-ripening tomato or corn chips) that has
been produced using biotechnology?
a) Yes

16.

b) No

c) Uncertain

Would you purchase a meat product (example bST milk) that has been produced using biotechnology?
a) Yes

b) No

c) Uncertain

SECTION V: Consumer Use of Food labels

17.

How often do you read the nutritional section of food labels before buying a familiar food product? (Circle one)
a) Always

18.

d) Rarely

e) Never

b) Often

c) Sometimes

d) Rarely

e) Never

How often do you read the nutritional section of food labels before buying a new food product? (Circle one)
a) Always

20.

c) Sometimes

How often do you read the ingredients section of food labels before buying a familiar food product? (Circle one)
a ) Always

19.

b) Often

b) Often

c) Sometimes

d) Rarely

e) Never

How often do you read the ingredients section of food labels before buying a new food product? (Circle one)
a) Always

b) Often

c) Sometimes

d) Rarely

e) Never

Section VI: Demographics
All information is confidential

1.

Gender (Circle one)
a) Male

2.

b) Female

Which of the following best describes your age category in years? (Circle one)
a) 18 – 24
b) 25 – 34

c) 35 – 44
d) 45 – 54

e) 55 – 64
f) 65 or older
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3.

How many members of your household are in the following age groups? (List all that apply)
a) Infants 0-24 months_________________
b) Children 2-17 years _________________
c) Adults 18 or older _________________

4.

Which of the following best describes your ethnic background? (Circle one)
a) African American
b) American Indian

5.

b) Single

Which of the following categories best describes your annual 2001 income? (Circle one)
a) Less than $15,000
b) $15,000 - $29,999
c) $30,000 - $44,999

8.

d) Some college
e) Bachelor degree
f) Post graduate work

What is your marital status? (Circle one)
a) Married

7.

e) Caucasian (white)
f) Other ____________

Please indicate the highest education attained. (Circle one)
a) Less than High school
b) High school
c) Technical college

6.

c) Asian
d) Hispanic

d) $45,000 - $59,999
e) $60,000 - $74,999
f) $75,000 - $89,999

g) $90,000 - $104, 999
h) $105,000 - $119,999
i) More than $120,000

Please chose the one category that most closely describes your occupation? (Circle one)
a)
c)
e)
g)

Business
Engineering
Government
Housewife

b)
d)
f)
h)

Agriculture and Natural Resources
Education
Healthcare
Student

i) Retired

j) Self-employed

k) Unemployed

l) Other ____________

Please use the space below to make any additional comments or questions

Thank you for your time and cooperation in helping to make this a successful study
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Department of Agricultural Economics an
101 Agricultural Administration Building
Louisiana State University
Baton Rouge, LA 70803-5604
(225) 578-3282
FAX: (225) 578-2716

June 5, 2002

Dear Sir or Madam:
As you may or may not know, biotechnology is being used more often in the production of certain food
products. Biotechnology is the use of scientific techniques to make new or better products. It has the
potential to make crop more nutritious, taste better, last longer, and naturally resist insects, viruses and
herbicides. It is also being used in the pharmaceutical, manufacturing, food processing and environmental
industries.
The department of Agricultural Economics and Agribusiness at Louisiana State University is conducting
a study of biotechnology and labeling of foods made from biotechnology. The enclosed survey is intended
to collect information about your knowledge of biotechnology, and the types of labeling formats you would
prefer for food products made using biotechnology.
The survey will help us and the food industry better understand how consumers use food labels. The results
will also help the food industry better understand how consumers view biotechnology. Consequently, your
participation is very important to the success of this study.
All of your responses are strictly confidential and will not be used for any purposes other than this study.
Please take a few minutes to fill out the questionnaire and return it in the postage-paid envelope.
If you have any questions regarding the survey please contact Dr. Wes Harrison at wharrison@agctr.lsu.edu,or
Mr. Everald Mclennon at smclen1@lsu.edu. Or call us at 225-578-2595.
Thank you for you participation.
Sincerely,

R. Wes Harrison, Ph. D.
Associate Professor
Food Marketing

THE LOUISIANA AGRICULTURAL EXPERIMENT STATION PROVIDES EQUAL OPPORTUNITIES IN PROGRAMS AND EMPLOYMENT
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Department of Agricultural Economics an
101 Agricultural Administration Building
Louisiana State University
Baton Rouge, LA 70803-5604
(225) 578-3282
FAX: (225) 578-2716

June 19, 2002

Dear Sir or Madam:
About two weeks ago, a questionnaire seeking information about agricultural food production and
biotechnology was sent to you. The survey deals with the consumer=s knowledge of biotechnology and
labeling formats you would prefer for food products made using biotechnology. You were selected as an
important participant in this study.
As of today, we have not yet received your completed questionnaire. I am writing to convey the importance
of your response to this study. The survey provides an opportunity for your input into the labeling of these
type foods.
If you have recently completed and returned the survey, please accept our sincere thanks. If not, I have
enclosed another copy for your convenience. I urge you to please take a few minutes, fill out the
questionnaire and return it in the postage-paid envelope.
Please be assured that all responses are strictly confidential and will not be used for any purposes other than
this study.
If you have any questions regarding the survey please contact Dr. Wes Harrison at wharrison@agctr.lsu.edu,or
Mr. Everald Mclennon at smclen1@lsu.edu. Or call us at 225-578-2595.
Thank you for you participation, your cooperation is greatly appreciated.
Sincerely,

R. Wes Harrison, Ph. D.
Associate Professor
Food Marketing

THE LOUISIANA AGRICULTURAL EXPERIMENT STATION PROVIDES EQUAL OPPORTUNITIES IN PROGRAMS AND EMPLOYMENT
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